Alerts will be sent to your verified email
Verify Email
FREDUN
|
Fredun Pharma
|
Wanbury
|
Lincoln Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.84 % | -11.27 % | 15.1 % |
|
5yr average Equity Multiplier
|
2.85 | -1.35 | 1.26 |
|
5yr Average Asset Turnover Ratio
|
1.08 | 1.54 | 0.82 |
|
5yr Avg Net Profit Margin
|
3.9 % | 5.09 % | 14.59 % |
|
Price to Book
|
5.62 | 14.37 | 1.29 |
|
P/E
|
44.8 | 19.82 | 11.52 |
|
5yr Avg Cash Conversion Cycle
|
175.29 Days | -103.0 Days | -6.41 Days |
|
Inventory Days
|
146.68 Days | 21.96 Days | 43.91 Days |
|
Days Receivable
|
142.46 Days | 61.39 Days | 91.75 Days |
|
Days Payable
|
112.95 Days | 194.51 Days | 128.38 Days |
|
5yr Average Interest Coverage Ratio
|
2.62 | 2.13 | 63.13 |
|
5yr Avg ROCE
|
22.71 % | -37.9 % | 19.81 % |
|
5yr Avg Operating Profit Margin
|
9.7 % | 7.72 % | 18.35 % |
|
5 yr average Debt to Equity
|
0.93 | 0.2 | 0.0 |
|
5yr CAGR Net Profit
|
25.5 % | n/a | 5.76 % |
|
5yr Average Return on Assets
|
4.18 % | 7.92 % | 11.92 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
43.06 % | 43.07 % | 49.78 % |
|
Share Pledged by Promoters
|
0.0 | 62.18 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-7.28 % | 3.23 % | 3.44 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Fredun Pharma
|
Wanbury
|
Lincoln Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|